Mirae Asset Global Investments Co., Ltd. Dice Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$25.86 - $46.71 $2,508 - $4,530	-97 Reduced 0.58%	16,488 $766,000
Q1 2023 May 04, 2023	SELL	$26.05 - $32.31 $781 - $969	-30 Reduced 0.18%	16,585 $475,000
Q4 2022 Feb 09, 2023	BUY	$19.77 - $42.23 $95,054 - $203,041	4,808 Added 40.72%	16,615 $518,000
Q3 2022 Nov 10, 2022	BUY	$14.97 - $22.65 $176,750 - $267,428	11,807 New	11,807 $239,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.